Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	06 Jan 2026	Ajanta Pharma	Consensus Share Price Target	2949.20	2999.77	-	1.71	buy	pdf Detailed Estimates
	06 May 2023	Ajanta Pharma	BOB Capital Markets Ltd. Reco Target	2949.20	1520.00	1298.45 (127.13%)	Target met	Buy	pdf post cache	Broker Report Ajanta Pharma (BUY): Margins appear to have bottomed out; raise to BUY BOB Capital Markets Ltd. Strong India and US growth in Q4 (17% YoY each) offset by declines in other businesses pdf Copy Link Share on Share on Share on Share on Alert
	06 May 2023	Ajanta Pharma	Motilal Oswal Target	2949.20	1490.00	1298.45 (127.13%)	Target met	Buy	pdf post cache	Broker Report Disruption in Africa segment/higher opex drags earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	10 Mar 2023	Ajanta Pharma	Motilal Oswal Target	2949.20	1410.00	1219.90 (141.76%)	Target met	Buy	pdf post cache	Broker Report Healthy Work-in-progress on reducing cost pressure to boost outlook Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	02 Feb 2023	Ajanta Pharma	ICICI Direct Target	2949.20	1385.00	1191.50 (147.52%)	Target met	Buy	pdf post cache	Broker Report Ajanta Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	04 Nov 2022	Ajanta Pharma	ICICI Direct Target	2949.20	1505.00	1256.20 (134.77%)	Target met	Buy	pdf post cache	Broker Report Ajanta Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	04 Nov 2022	Ajanta Pharma	BOB Capital Markets Ltd.	2949.20	1470.00	1256.20 (134.77%)	Target met	Hold	pdf post cache	Broker Report Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD BOB Capital Markets Ltd. Q2 revenue growth muted at 6% YoY as lower Africa/US sales offset a strong uptick in India/Asia business pdf Copy Link Share on Share on Share on Share on Alert
	04 Nov 2022	Ajanta Pharma	Motilal Oswal	2949.20	1560.00	1256.20 (134.77%)	Target met	Buy	pdf post cache	Broker Report India and Asia drives, while the US and Africa drag earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	29 Jul 2022	Ajanta Pharma	ICICI Direct	2949.20	1495.00	1278.60 (130.66%)	Target met	Buy	pdf post cache	Broker Report Ajanta Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Ajanta Pharma	ICICI Direct	2949.20	1305.00	1214.80 (142.77%)	Pre-Bonus/ Split	Hold	pdf post cache	Broker Report Ajanta Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2022	Ajanta Pharma	ICICI Direct	2949.20	1955.00	1684.70 (75.06%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Ajanta Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

Near 52W High of ₹3094.25

Ajanta Pharma Ltd. share price target

Ajanta Pharma Ltd. has an average share price target of 2963.33. The consensus estimate represents an upside of 0.48% from the last price of 2949.20. View 9 reports from 6 analysts offering long-term price targets for Ajanta Pharma Ltd..

Ajanta Pharma (BUY): Margins appear to have bottomed out; raise to BUY

Disruption in Africa segment/higher opex drags earnings

Healthy Work-in-progress on reducing cost pressure to boost outlook

Ajanta Pharmaceuticals

Ajanta Pharmaceuticals

Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD

India and Asia drives, while the US and Africa drag earnings

Ajanta Pharmaceuticals

Ajanta Pharmaceuticals

Ajanta Pharmaceuticals

Advisor Screeners